To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT04566666. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy And Safety of SCD-044 in the Treatment of Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, randomized, double-blind, placebo-controlled study in subjects with moderate to severe plaque psoriasis.
Study identification
- NCT ID
- NCT04566666
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 263 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- SCD-044_Low Dose (Dose 1) Drug
- SCD-044_Intermediate Dose (Dose 2) Drug
- SCD-044_High Dose (Dose 3) Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 25, 2021 (Actual)
- Primary completion
- Nov 20, 2024 (Actual)
- Completion
- Aug 27, 2025 (Actual)
- Last update posted
- Jan 20, 2026
2021 – 2025
United States locations
- U.S. sites
- 29
- U.S. states
- 10
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Yuma Clinical Trials, LLC | Yuma | Arizona | 85364 | — |
| T. Joseph Raoof Md, Imc./Encino Research Center | Encino | California | 91436 | — |
| Metropolis Dermatology | Los Angeles | California | 90017 | — |
| Axis Clinical Trials | Los Angeles | California | 90036 | — |
| Velocity Clinical Research | North Hollywood | California | 91606 | — |
| Unison Clinical Trials | Sherman Oaks | California | 91403 | — |
| Clarity Dermatology | Castle Rock | Colorado | 80109 | — |
| Accel Research Sites Network - Annexus Dermatology & Aestheitcs | DeLand | Florida | 32720 | — |
| Palm Beach Dermatology Group | Delray Beach | Florida | 33484 | — |
| Revival Research Corporation | Doral | Florida | 33122 | — |
| FXM Clinical Research Fort Lauderdale | Fort Lauderdale | Florida | 33308 | — |
| Direct Helpers Research Center | Hialeah | Florida | 33012 | — |
| Evolution Clinical Trials, Inc | Hialeah Gardens | Florida | 33016 | — |
| JD Medical Group, LLC | Miami | Florida | 33133 | — |
| MedOne Clinical Research, LLC | Miami | Florida | 33145 | — |
| Century Research LLC | Miami | Florida | 33173 | — |
| FXM Clinical Research Miami | Miami | Florida | 33175 | — |
| FXM Clinical Research Miramar | Miramar | Florida | 33027 | — |
| Adtremed Inc | Tampa | Florida | 33607 | — |
| Advanced Clinical Research Institute | Tampa | Florida | 33607 | — |
| Alliance Clinical Research of Tampa | Tampa | Florida | 33615 | — |
| Oracle Clinical Research | College Park | Georgia | 30349 | — |
| Physicians Research Group | West Lafayette | Indiana | 47906 | — |
| Revival research Institute, LLC | Troy | Michigan | 48084 | — |
| DFW Clinical Research, LLC | Dallas | Texas | 75234 | — |
| SMS Clinical Research | Mesquite | Texas | 75149 | — |
| Stride Clinical Research | Sugar Land | Texas | 77479 | — |
| Springville Dermatology/ CCT Research | Springville | Utah | 84663 | — |
| Skin DC Derm | Arlington | Virginia | 22209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 21 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04566666, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 20, 2026 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04566666 live on ClinicalTrials.gov.